NDC 72934-7040

CICLOPIROX 0.77% / SALICYLIC ACID 2%

Ciclopirox 0.77% / Salicylic Acid 2%

CICLOPIROX 0.77% / SALICYLIC ACID 2% is a Topical Shampoo in the Human Prescription Drug category. It is labeled and distributed by Sincerus Florida, Llc. The primary component is Ciclopirox Olamine; Salicylic Acid.

Product ID72934-7040_8903854a-0b6b-fb7c-e053-2995a90ab38c
NDC72934-7040
Product TypeHuman Prescription Drug
Proprietary NameCICLOPIROX 0.77% / SALICYLIC ACID 2%
Generic NameCiclopirox 0.77% / Salicylic Acid 2%
Dosage FormShampoo
Route of AdministrationTOPICAL
Marketing Start Date2019-05-17
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameSincerus Florida, LLC
Substance NameCICLOPIROX OLAMINE; SALICYLIC ACID
Active Ingredient Strength1 g/100g; g/100g
Pharm ClassesDecreased DNA Replication [PE],Decreased Protein Synthesis [PE],Decreased RNA Replication [PE],Protein Synthesis Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 72934-7040-6

120 g in 1 BOTTLE, PLASTIC (72934-7040-6)
Marketing Start Date2019-05-17
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 72934-7040-6 [72934704006]

CICLOPIROX 0.77% / SALICYLIC ACID 2% SHAMPOO
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-05-17

Drug Details

Active Ingredients

IngredientStrength
CICLOPIROX OLAMINE1 g/100g

OpenFDA Data

SPL SET ID:8903854a-0b6a-fb7c-e053-2995a90ab38c
Manufacturer
UNII

Pharmacological Class

  • Decreased DNA Replication [PE]
  • Decreased Protein Synthesis [PE]
  • Decreased RNA Replication [PE]
  • Protein Synthesis Inhibitors [MoA]
  • Decreased DNA Replication [PE]
  • Decreased Protein Synthesis [PE]
  • Decreased RNA Replication [PE]
  • Protein Synthesis Inhibitors [MoA]

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.